Skip to main content

Todd Johnson, Risa Lavizzo-Mourey, John Berriman

MDS Pharma Services has appointed Todd Johnson to be senior vice president of strategy and corporate development.
 
Johnson previously was a strategic consultant for pharmaceutical and biotechnology companies at McKinsey & Company. He also was CEO of Tangerine Technologies and was a cancer researcher at Harvard’s Dana-Farber Cancer Institute, the University of Pennsylvania, and at the National Institutes of Health
 

 
Beckman Coulter said this week that Risa Lavizzo-Mourey has resigned from the company’s board of directors, effective June 1. She is currently president and CEO of the Robert Wood Johnson Foundation. Beckman said it is conducting a search for candidates to replace Lavizzo-Mourey.
 

 
Belgian biomarker company Pronota has appointed John Berriman chairman. Berriman was chairman of Algeta and is a director at MicroMet, Ablynx, and Oxxon Therapeutics.
 
He had been a director at Abingworth Management, worked at Celltech Group and Celltech Therapeutics, and founded Celltech Biologics. Berriman also was a director and co-founder at Solexa, chairman of Chroma Therapeutics, and was a director at Epigenomics, Alnylam, and XCounter.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.